Cargando…
Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act
Cell therapy and regenerative medicine technologies require strict cell manufacturing procedures to be defined and addressed. Maintenance of the aseptic environment is critical to preclude extrinsic contamination risks, similar to conventional pharmaceutical manufacturing. However, intrinsic contami...
Autores principales: | Mizutani, Manabu, Samejima, Hazuki, Terunuma, Hiroshi, Kino-oka, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581811/ https://www.ncbi.nlm.nih.gov/pubmed/31245497 http://dx.doi.org/10.1016/j.reth.2016.06.004 |
Ejemplares similares
-
Variation in the manufacturing reproducibility of autologous cell-based products depending on raw material shipment conditions
por: Mizutani, Manabu, et al.
Publicado: (2019) -
Medical Practitioners and the Midwives Act
Publicado: (1907) -
Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products
por: Mizutani, Manabu, et al.
Publicado: (2022) -
Contravention of Medical Practitioners Act. Fraudulent Registration
Publicado: (1859) -
Understanding the formation and behaviors of droplets toward consideration of changeover during cell manufacturing
por: Ogawa, Yuuki, et al.
Publicado: (2019)